
Pharmala Biotech Holdings Investor Relations Material
Latest events

Q1 2025
Pharmala Biotech Holdings
Access the full event backlog
Slides, Transcripts, and Reports from 12,000+ public companies
Latest reports from Pharmala Biotech Holdings Inc
Access all reports
Pharmala Biotech Holdings Inc is a biotechnology company focused on the research, development, and manufacturing of medical-grade psychedelic compounds. The company specializes in the production of MDMA and related substances for use in scientific research and potential therapeutic applications. Its activities include active pharmaceutical ingredient (API) synthesis, regulatory compliance, and supply to clinical trial sponsors and academic institutions. The company is headquartered in Vancouver, Canada, and its shares are listed on the CSE.
Latest articles
)
Moncler: From the Mountains to the Runway
The story of Moncler, all the way from its beginnings in the Alps to its journey to some of the most prestigious runways in the world.
16 Apr 2025
)
eToro: Innovation, Growth, and IPO Plans
eToro was founded in 2007 and has grown into a global trading platform with over 40 million users and an extensive offering across several asset classes.
10 Apr 2025
)
Yum! Brands: The Company Behind Pizza Hut, KFC, and Taco Bell
Yum! Brands started at PepsiCo in the 1970s and is home to some of the most well-known brands in the world, such as Pizza Hut, KFC, and Taco Bell.
9 Apr 2025
Ticker symbol
MDMA
Country
🇨🇦 Canada